SALL4 and intrahepatic cholangiocarcinoma: Downregulation of SALL4 contributed to a decrease in B-cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1) expression and inactivated the Wnt3a/β-catenin signaling pathway in intrahepatic cholangiocarcinoma (ICC) [38].